BLINCYTO, created in 2013 (United States), from 142 sister brands and 17477 competing brands. BLINCYTO is owned by Amgen, listed on the stock exchange of New York BLINCYTO belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
Amgen
(BLINCYTO)
over 5 years*
USD 394.73